U.S. Markets closed

Today's Research Reports on Trending Tickers: TherapeuticsMD and Endo International

NEW YORK, NY / ACCESSWIRE / September 28, 2018 / U.S. markets finished higher on Thursday as the jobless claims increase was smaller than expected and second quarter GDP rose 3.1%, marking the best growth in 2 years. The Dow Jones Industrial Average gained 0.21 percent to close at 26,439.93, while the S&P 500 Index jumped 0.28 percent to close at 2,914.00. The Nasdaq Composite Index climbed 0.65 percent to close at 8,041.97.

''Today's stock market gains look to me like a relief rally following yesterday's Fed meeting. The biggest risk yesterday had been that the 10- and 30-year yields, which were retesting their May highs near 3.12% and 3.24% respectively, would break out on hawkish Fed news which could spark a stock market selloff as occurred back in February,'' according to Colin Cieszynski, chief market strategist at SIA Wealth Management. ''Treasury yields have dropped off since the Fed meeting, taking some of the recent pressure off of stocks and enabling indices to rebound,'' Cieszynski added.

RDI Initiates Coverage on:

TherapeuticsMD, Inc.

Endo International plc

TherapeuticsMD's stock moved 1.34% lower Thursday, to close the day at $6.62. The stock recorded a trading volume of 1,314,739 shares, which was below its three months average volume of 2,250,770 shares. In the last year, TherapeuticsMD's shares have traded in a range of 4.34 - 7.66. The share price has gained 52.53% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $6.08 is above its 200-day moving average of $6.01. Shares of TherapeuticsMD have gained roughly 7.47 percent in the past month and are up 9.6 percent year-to-date.

Access RDI's TherapeuticsMD, Inc. Research Report at:

On Thursday, shares of Endo International recorded a trading volume of 2,760,514 shares, which was below the three months average volume of 4,779,839 shares. The stock ended the day 3.41% higher at $16.70. The share price has fallen 4.35% from its 52 week high with a 52 week trading range of 5.27 - 17.46. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $16.14 is above its 200-day moving average of $9.93. Shares of Endo International have gained roughly 3.66 percent in the past month and are up 115.48 percent year-to-date.

Access RDI's Endo International plc Research Report at:

Our Actionable Research on TherapeuticsMD, Inc. (NASDAQ: TXMD) and Endo International plc (NASDAQ: ENDP) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.


For any questions, inquiries, or comments reach out to us directly at:




CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com